Sullivan & Cromwell LLP Logo
  • Home
  • Lawyers
  • Practices
  • Insights
  • About
  • Careers
  • Alumni
  • Twitter icon
  • LinkedIn icon
  •  icon
  • Podcasts icon
© 2025 Sullivan & Cromwell LLP
    • Home
    • Lawyers
    • Practices
    • Insights
    • About
    • Careers
    • Alumni
    Home /  Insights /  Video And Podcasts /  Podcast
    Podcasts

    Industry and Regulatory Trends in Pharmaceutical M&A

    • Our Lawyers
    • Related Practices
    March 24, 2021

    In this episode of S&C’s Critical Insights podcast, Frank Aquila, Global Head of M&A, and Matt Hurd, co-head of our Healthcare & Life Sciences group, examine industry and regulatory trends that will reshape pharmaceutical M&A in the coming years. Frank and Matt explore how innovation continues to drive new deal-making opportunities in the pharmaceutical industry, most recently in the development of non-traditional vaccine technologies. They also discuss the current deal landscape in pharmaceutical M&A and what we can expect from the market in the rest of 2021.

    Read More
    Stay Updated

    Subscribe to stay current on S&C Insights.

    Our Lawyers

    Our Lawyers

    Francis J. Aquila Headshot Photo
    Francis J. Aquila
    New York
    +1-212-558-4048
    Email
    vCard
    Matthew G. Hurd Headshot Photo
    Matthew G. Hurd
    New York
    +1-212-558-4000
    Email
    vCard
    Read More

    Related Practices

    • Healthcare & Life Sciences
    • Mergers & Acquisitions
    Sullivan & Cromwell LLP Logo
    • Twitter icon
    • LinkedIn icon
    • RSS Feed icon
    • Podcasts icon
    • Home
    • Contact Us
    • Information Policy Relating to Cookies
    • Privacy Policy
    • California Privacy Policy
    • Website Notice
    • Attorney Advertising Notice
    © 2025 Sullivan & Cromwell LLP